NCT00501137View on ClinicalTrials.gov

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

PHASE3CompletedINTERVENTIONAL

Enrollment

830

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

December 31, 2010

Conditions

Cervical CancerGenital Warts

Interventions

BIOLOGICAL

HPV (Human Papillomavirus) Vaccine

HPV (Human Papillomavirus) Vaccine received by all participants in groups 1, 2 and 3 according to the arm

Trial Locations (1)

Unknown

Vaccine Evaluation Centre, Vancouver

All Listed Sponsors

collaborator

Ministry of Health, British Columbia

OTHER_GOV

lead

Simon Dobson

OTHER

NCT00501137 - A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine | Biotech Hunter | Biotech Hunter